Just before I was furloughed from the hardware store I work at I

bought lots of plants so at least that makes it a more calming,

green space.

Depression feels like a weight on my shoulders. It means that I

don't know whether when I wake up in the morning I will feel a
light but overbearing sense of sadness, or whether every single
little thing is going to feel like the end of the world.

I'm not a stranger to spending lots of time isolated in my room, so

maybe in some way I am better prepared for this lockdown than
others. At my lowest I used to hide away in my room, sometimes
for months. I'd stop replying to people who got in touch and I'd
lose hours and hours just staring at my phone in bed.

Luckily, since being at university I've made good friends who will
just turn up at my room and drag me out of there to do something
that will make me happy or distract me.

Men with advanced prostate cancer can take highly targeted

hormone therapies at home instead of coming into hospital for
chemotherapy, NHS England says.

Experts say it will relieve pressure on the NHS, which wants all
urgent and essential cancer treatments to continue during the
coronavirus pandemic.

The drugs are also smarter, kinder treatments and could extend
the lives of many more patients, they say.

This precision-medicine approach is already used to treat other

cancers.

'Huge shock'

Diagnosed with advanced prostate cancer in February, Stuart

Fraser, 66, from Ashtead, in Surrey, will now take four
enzalutamide tablets a day.

"Being diagnosed was a huge shock," he said.

"What made it even more worrying was that, because of
coronavirus, I was told I couldn't have the usual treatment of
chemotherapy, which would have affected my immune system.

"When I heard about other possible treatments like abiraterone

and enzalutamide, I launched a petition to try to make sure men
like me could get hold of it.

"That's why it's such great news that now no-one will be in the
same position I was at the beginning of all this."

Patients intolerant to enzalutamide, will be given abiraterone,

which stops the body producing testosterone.

Until now, in England and Wales, the drugs were available only to
patients for whom other hormone therapy had stopped working,
although abiraterone was recommended in Scotland as a first-line
treatment earlier this year.

Now, doctors can prescribe them when a patient is first

diagnosed.

'Hard-pressed hospitals'

Prof Nick James, of the Institute of Cancer Research, in London,

who has led major trials into targeted prostate cancer drugs, said:
"I'm pleased and relieved that many more men should now benefit
from targeted hormone therapies right from when they are first
diagnosed.

"It will greatly lower the risk of exposing vulnerable patients to the
coronavirus and lightens the load on our hard-pressed hospitals.

"Men can take their tablets at home and have their bloods
checked by their GP.

"And, unlike chemotherapy, enzalutamide and abiraterone have no

significant effects on patients' immune system."